Alice Lione – Pagina 40 – AMD

Alice Lione

Luglio 24, 2025 Alice Lione

Interleukin-6 in heart failure with reduced ejection fraction and the effect of dapagliflozin: an exploratory analysis of the dapagliflozin and prevention of adverse outcomes in heart failure trial

Docherty KF, McDowell K, Welsh P, et al.
JACC Heart Fail. 2025;13(7):102393.

Leggi

Luglio 24, 2025 Alice Lione

Stem cell-derived pancreatic beta cells: a step closer to functional diabetes treatment?

Ogieuhi IJ, Agbo CE, Ajekiigbe VO, et al.
BMC Endocr Disord. 2025;25(1):181.

Leggi

Luglio 24, 2025 Alice Lione

Challenges and opportunities for understanding the pathogenesis of type 1 diabetes: an Endocrine Society Scientific Statement

Michels AW, Brusko TM, Evans-Molina C, et al.
J Clin Endocrinol Metab. 2025:dgaf267.

Leggi

Luglio 21, 2025 Alice Lione

Neurodegeneration and stroke after semaglutide and tirzepatide in patients with diabetes and obesity

Lin HT, Tsai YF, Liao PL, et al.
JAMA Netw Open. 2025;8(7):e2521016.

Leggi

Luglio 21, 2025 Alice Lione

Association between remnant cholesterol and low-density lipoprotein cholesterol discordance and type 2 diabetes or prediabetes: results from NHANES

Xin Y, Wang Y, Shu Y, Liang H, Yang Y
BMC Endocr Disord. 2025;25(1):168.

Leggi

Luglio 21, 2025 Alice Lione

Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study

Buckley AJ, Tan GD, Gruszka-Goh M, et al.
Diabetologia. Pub. online 10 Jul 2025.

Leggi

Luglio 21, 2025 Alice Lione

Dapagliflozin’s impact on hormonal regulation and ketogenesis in type 1 diabetes: a randomised controlled crossover trial

Gübeli A, Steiner N, Limacher A, et al.
Diabetologia. Pub. online 9 Jul 2025.

Leggi

Luglio 21, 2025 Alice Lione

Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: an observational study comparing matched cohorts

Caruso PD, Angelino S, Matrone R, et al.
Diabetes Obes Metab. Pub. online 7 Jul 2025.

Leggi

Luglio 21, 2025 Alice Lione

Time to progression to proliferative diabetic retinopathy in patients with type 2 diabetes

Kim IM, Radgoudarzi N, Chen EM, et al.
JAMA Netw Open. 2025;8(7):e2521150.

Leggi

Luglio 21, 2025 Alice Lione

AGGIORNAMENTO NOTA 100 – Prescrizione degli inibitori del SGLT2, degli agonisti recettoriali del GLP1, degli inibitori del DPP4, dei doppi agonisti recettoriali GIP/GLP1 e loro associazioni nel trattamento del diabete mellito tipo 2

18/07/2025

Leggi